Key Insights
The Asia Pacific eubiotics market, encompassing probiotics, prebiotics, organic acids, and essential oils, is experiencing robust growth, projected at a 5.80% CAGR from 2025 to 2033. This expansion is driven by several factors. Increasing consumer awareness of gut health and its impact on overall well-being fuels demand for probiotic-rich foods and supplements. The rising prevalence of digestive disorders and the growing adoption of preventative healthcare measures further contribute to market growth. Furthermore, the burgeoning animal feed industry, utilizing eubiotics to enhance animal health and productivity, significantly boosts market volume. Key players like Biomin Holding GmbH, Danisco A/S, and Chr. Hansen A/S are driving innovation through the development of advanced eubiotics formulations, catering to specific needs across various segments. The market is segmented by product type (probiotics, prebiotics, organic acids, essential oils), with probiotics currently dominating due to established consumer familiarity and a wider range of applications. However, the prebiotics segment is poised for substantial growth, fuelled by increasing understanding of its synergistic role with probiotics in optimizing gut microbiota. Regional variations exist, with China, Japan, India, and South Korea representing significant market contributors within the Asia Pacific region due to their large populations and expanding middle classes with greater disposable income to invest in health and wellness products.
The Asia Pacific eubiotics market faces some challenges despite its positive trajectory. Regulatory hurdles and stringent quality control standards related to food safety and supplement approval can impact market entry and expansion for smaller players. Price fluctuations in raw materials, particularly for certain types of probiotics and prebiotics, can affect profitability. Moreover, educating consumers about the benefits of different eubiotics and their specific applications remains crucial for driving wider adoption. However, the overall market outlook remains positive, with continued innovation, investment in research and development, and a growing focus on natural and functional ingredients promising to propel growth over the forecast period. The increasing integration of eubiotics into various food and animal feed applications will be a key driver in shaping the market landscape in the coming years.

Asia Pacific Eubiotics Market Report: 2019-2033 Forecast
Uncover lucrative growth opportunities in the dynamic Asia Pacific Eubiotics market with this comprehensive report. This in-depth analysis provides a detailed overview of the market, covering market size, growth drivers, key segments (Probiotics, Prebiotics, Organic Acids, Essential Oils), leading players (Biomin Holding GmbH, Danisco A/S, Chr. Hansen A/S, and more), and future growth projections. The report covers the period 2019-2033, with a focus on the 2025-2033 forecast period. This study is essential for businesses, investors, and industry stakeholders seeking to understand and capitalize on the burgeoning Asia Pacific eubiotics market.
Asia Pacific Eubiotics Market Concentration & Dynamics
The Asia Pacific eubiotics market is characterized by a moderately concentrated landscape with several key players holding significant market share. In 2025, the top five companies are estimated to hold approximately xx% of the market, with Biomin Holding GmbH, Danisco A/S, and Chr. Hansen A/S among the leading players. The market exhibits a dynamic interplay of innovation, regulatory frameworks, and evolving consumer preferences.
Market Dynamics:
- Innovation Ecosystem: Significant investment in R&D by major players is driving the development of novel eubiotics with enhanced efficacy and targeted applications. This includes advancements in prebiotic formulation and probiotic strain selection.
- Regulatory Framework: Varying regulatory landscapes across the Asia Pacific region influence product approvals and market entry strategies. Harmonization efforts and evolving regulations related to food safety and animal feed are key considerations.
- Substitute Products: Competition from alternative feed additives and approaches in animal nutrition poses a challenge to market growth, requiring continuous innovation to maintain a competitive edge.
- End-User Trends: Growing consumer awareness of gut health and animal welfare is fuelling demand for high-quality eubiotics. The increasing adoption of sustainable and organic farming practices is also impacting market trends.
- M&A Activities: The market has witnessed xx M&A deals in the past five years, indicating a trend of consolidation and expansion among key players. This strategic activity aims to enhance market presence, broaden product portfolios, and access new technologies.
Asia Pacific Eubiotics Market Industry Insights & Trends
The Asia Pacific eubiotics market is experiencing robust growth, with an estimated market size of xx Million in 2025 and a projected Compound Annual Growth Rate (CAGR) of xx% from 2025 to 2033. This expansion is propelled by several key factors:
- Rising Demand for Animal Protein: Growing populations and increasing disposable incomes across the region are driving demand for animal protein, which, in turn, fuels the consumption of eubiotics in animal feed.
- Growing Awareness of Gut Health: Enhanced understanding of the gut microbiome’s importance in both human and animal health has significantly increased demand for eubiotics in both food and animal feed applications.
- Technological Advancements: Innovations in probiotic strain development, prebiotic formulation, and targeted delivery systems are constantly improving eubiotics’ efficacy and market acceptance. The rising use of precision fermentation and synthetic biology is poised to further revolutionize the industry.
- Stringent Government Regulations: Increased government scrutiny of feed additives and growing focus on animal welfare and food safety are driving demand for high-quality and safe eubiotics.
- Evolving Consumer Preferences: A shift towards natural and sustainable food products and animal feed is creating significant opportunities for organic and sustainably sourced eubiotics.

Key Markets & Segments Leading Asia Pacific Eubiotics Market
The report highlights China and India as the dominant markets within the Asia Pacific region, driven by their large livestock populations and increasing animal protein consumption. Within the segment breakdown:
- Probiotics: This segment holds the largest market share driven by increased adoption in animal feed and human nutrition due to their health-promoting attributes. Key drivers include:
- Rapid Growth of Aquaculture: The growing aquaculture industry significantly increases the demand for probiotics in fish feed.
- Government Initiatives: Supportive government policies for sustainable animal farming are boosting probiotic adoption.
- Prebiotics: The prebiotics segment is experiencing substantial growth due to growing awareness of its role in gut health, particularly in human nutrition.
- Rising Disposable Incomes: A rise in disposable income fuels increased expenditure on health and wellness products, including prebiotics.
- Increased Health Consciousness: A heightened awareness of the gut microbiota and its importance for overall well-being is contributing to market growth.
- Organic Acids: The use of organic acids as feed additives is increasing due to their effectiveness in improving animal health and feed efficiency.
- Focus on Animal Health: The expanding focus on livestock health and disease prevention fuels the adoption of organic acids.
- Technological Improvements: Enhanced production technologies and the availability of more efficacious organic acid products are encouraging further adoption.
- Essential Oils: Essential oils are gaining traction as natural feed additives, driven by the growing preference for natural products and their beneficial impacts on animal health.
- Growing Demand for Natural Alternatives: A shift toward natural and sustainable solutions in animal agriculture fuels market expansion.
- Increasing Research and Development: Investment in research on the efficacy of essential oils is showcasing their potential benefits.
Asia Pacific Eubiotics Market Product Developments
Recent years have witnessed significant advancements in eubiotics technology, including the development of novel probiotic strains with enhanced efficacy, targeted delivery systems, and the use of advanced analytics to optimize eubiotics production and application. These developments enhance product performance, improve animal health, and bolster the competitive advantage of eubiotics manufacturers. Companies are focusing on developing tailored eubiotics for specific animal species and applications, further increasing market appeal.
Challenges in the Asia Pacific Eubiotics Market Market
The Asia Pacific eubiotics market faces challenges like inconsistent regulatory frameworks across different countries, leading to varying approval processes and potential delays in market entry. Supply chain disruptions and fluctuating raw material prices also impact profitability. Furthermore, intense competition from both established and emerging players exerts pressure on margins and necessitates continuous innovation to stay ahead. These challenges, if not managed effectively, could significantly hinder market growth. The combined impact of these issues is estimated to reduce annual market growth by approximately xx%.
Forces Driving Asia Pacific Eubiotics Market Growth
Several factors drive the Asia Pacific eubiotics market's growth, including the increasing demand for animal protein, fuelled by population growth and rising incomes. Technological advancements in strain development and delivery systems enhance efficacy. Government regulations promoting sustainable agriculture further stimulate the market. Finally, the growing consumer awareness of gut health and its relation to overall wellness significantly increases demand for eubiotics in both human nutrition and animal feed.
Long-Term Growth Catalysts in Asia Pacific Eubiotics Market
Long-term growth in the Asia Pacific eubiotics market is expected to be driven by strategic partnerships between industry players and research institutions to accelerate innovation and product development. Expanding into new markets and developing tailored eubiotics for specific animal species and applications will also contribute significantly to sustained market expansion.
Emerging Opportunities in Asia Pacific Eubiotics Market
The Asia Pacific eubiotics market presents significant opportunities for personalized nutrition solutions and the development of eubiotics tailored to specific animal breeds and dietary needs. The rising demand for natural and sustainable products presents opportunities for organic and sustainably sourced eubiotics. Exploring new markets in Southeast Asia and expanding into value-added applications in human health will further fuel market growth.
Leading Players in the Asia Pacific Eubiotics Market Sector
- Biomin Holding GmbH
- Danisco A/S (now part of DuPont)
- Chr. Hansen A/S
- Biovet Joint Stock Company
- Orffa International Holding B.V.
- Novus International Inc.
- DSM Nutritional Products Inc.
- Life Products Inc.
- Kemin Industries Inc.
- Calpis Co. Ltd.
- Bluestar Adisseo Company
- Lallemand Inc.
Key Milestones in Asia Pacific Eubiotics Market Industry
- 2020: Several key players launched new lines of probiotics specifically tailored for aquaculture applications.
- 2021: Increased government regulations in several key markets led to a focus on transparency and traceability within the eubiotics supply chain.
- 2022: A significant merger between two prominent players reshaped the market landscape, leading to greater market consolidation.
- 2023: The release of several groundbreaking research papers on the efficacy of specific prebiotic strains accelerated product innovation.
Strategic Outlook for Asia Pacific Eubiotics Market Market
The Asia Pacific eubiotics market is poised for significant growth in the coming years, driven by favourable demographics, technological advancements, and increasing regulatory support. Strategic opportunities exist in expanding product portfolios, targeting niche markets, and forging strategic partnerships to accelerate innovation and market penetration. The market's future success hinges on adopting sustainable practices, ensuring product safety and efficacy, and adapting to evolving consumer preferences.
Asia Pacific Eubiotics Market Segmentation
-
1. Type
-
1.1. Probiotics
- 1.1.1. Lactobacilli
- 1.1.2. Bifidobacteria
- 1.1.3. Other Probiotics
-
1.2. Prebiotics
- 1.2.1. Inulin
- 1.2.2. Fructo-Oligosaccharides
- 1.2.3. Galacto-Oligosaccharides
- 1.2.4. Other Prebiotics
- 1.3. Organic Acids
- 1.4. Essential Oils
-
1.1. Probiotics
-
2. Geography
-
2.1. Asia-Pacific
- 2.1.1. China
- 2.1.2. India
- 2.1.3. Indonesia
- 2.1.4. Thailand
- 2.1.5. Japan
- 2.1.6. South Korea
- 2.1.7. Australia
- 2.1.8. Rest of Asia-Pacific
-
2.1. Asia-Pacific
Asia Pacific Eubiotics Market Segmentation By Geography
-
1. Asia Pacific
- 1.1. China
- 1.2. India
- 1.3. Indonesia
- 1.4. Thailand
- 1.5. Japan
- 1.6. South Korea
- 1.7. Australia
- 1.8. Rest of Asia Pacific

Asia Pacific Eubiotics Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.80% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rise in the Fish Meal and Fish Oil Production; Demand for Quality Animal Feed
- 3.3. Market Restrains
- 3.3.1. High Prices of Fish Meal and Fish Oil Products; Threat to Fish Reserves
- 3.4. Market Trends
- 3.4.1. Yeast Derived Probiotic Supplemets to Drive the Eubiotics Market Growth
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Probiotics
- 5.1.1.1. Lactobacilli
- 5.1.1.2. Bifidobacteria
- 5.1.1.3. Other Probiotics
- 5.1.2. Prebiotics
- 5.1.2.1. Inulin
- 5.1.2.2. Fructo-Oligosaccharides
- 5.1.2.3. Galacto-Oligosaccharides
- 5.1.2.4. Other Prebiotics
- 5.1.3. Organic Acids
- 5.1.4. Essential Oils
- 5.1.1. Probiotics
- 5.2. Market Analysis, Insights and Forecast - by Geography
- 5.2.1. Asia-Pacific
- 5.2.1.1. China
- 5.2.1.2. India
- 5.2.1.3. Indonesia
- 5.2.1.4. Thailand
- 5.2.1.5. Japan
- 5.2.1.6. South Korea
- 5.2.1.7. Australia
- 5.2.1.8. Rest of Asia-Pacific
- 5.2.1. Asia-Pacific
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. China Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 7. Japan Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 8. India Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 9. South Korea Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 10. Taiwan Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 11. Australia Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 12. Rest of Asia-Pacific Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2019-2031
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2024
- 13.2. Company Profiles
- 13.2.1 Biomin Holding GmbH
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 Danisco A/S
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Chr Hansen A/S
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Biovet Joint Stock Company
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Orffa International Holding B V
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Novus International Inc
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 DSM Nutritional Products Inc
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 Life Products Inc
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.9 Kemin Industries Inc
- 13.2.9.1. Overview
- 13.2.9.2. Products
- 13.2.9.3. SWOT Analysis
- 13.2.9.4. Recent Developments
- 13.2.9.5. Financials (Based on Availability)
- 13.2.10 Calpis Co Ltd
- 13.2.10.1. Overview
- 13.2.10.2. Products
- 13.2.10.3. SWOT Analysis
- 13.2.10.4. Recent Developments
- 13.2.10.5. Financials (Based on Availability)
- 13.2.11 Bluestar Adisseo Compan
- 13.2.11.1. Overview
- 13.2.11.2. Products
- 13.2.11.3. SWOT Analysis
- 13.2.11.4. Recent Developments
- 13.2.11.5. Financials (Based on Availability)
- 13.2.12 Lallemand Inc
- 13.2.12.1. Overview
- 13.2.12.2. Products
- 13.2.12.3. SWOT Analysis
- 13.2.12.4. Recent Developments
- 13.2.12.5. Financials (Based on Availability)
- 13.2.1 Biomin Holding GmbH
List of Figures
- Figure 1: Asia Pacific Eubiotics Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Asia Pacific Eubiotics Market Share (%) by Company 2024
List of Tables
- Table 1: Asia Pacific Eubiotics Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Asia Pacific Eubiotics Market Revenue Million Forecast, by Type 2019 & 2032
- Table 3: Asia Pacific Eubiotics Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 4: Asia Pacific Eubiotics Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Asia Pacific Eubiotics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: China Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: Japan Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: India Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: South Korea Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Taiwan Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Australia Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Rest of Asia-Pacific Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Asia Pacific Eubiotics Market Revenue Million Forecast, by Type 2019 & 2032
- Table 14: Asia Pacific Eubiotics Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 15: Asia Pacific Eubiotics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 16: China Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: India Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Indonesia Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Thailand Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Japan Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: South Korea Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Australia Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Rest of Asia Pacific Asia Pacific Eubiotics Market Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Asia Pacific Eubiotics Market?
The projected CAGR is approximately 5.80%.
2. Which companies are prominent players in the Asia Pacific Eubiotics Market?
Key companies in the market include Biomin Holding GmbH, Danisco A/S, Chr Hansen A/S, Biovet Joint Stock Company, Orffa International Holding B V, Novus International Inc, DSM Nutritional Products Inc, Life Products Inc, Kemin Industries Inc, Calpis Co Ltd, Bluestar Adisseo Compan, Lallemand Inc.
3. What are the main segments of the Asia Pacific Eubiotics Market?
The market segments include Type, Geography.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Rise in the Fish Meal and Fish Oil Production; Demand for Quality Animal Feed.
6. What are the notable trends driving market growth?
Yeast Derived Probiotic Supplemets to Drive the Eubiotics Market Growth.
7. Are there any restraints impacting market growth?
High Prices of Fish Meal and Fish Oil Products; Threat to Fish Reserves.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Asia Pacific Eubiotics Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Asia Pacific Eubiotics Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Asia Pacific Eubiotics Market?
To stay informed about further developments, trends, and reports in the Asia Pacific Eubiotics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence